tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Phase III'

Nuvilex Funding Has Investors Preparing for Milestone Announcements in Late-Phase Clinical Trials

Nuvilex Funding Has Investors Preparing for Milestone Announcements in Late-Phase Clinical Trials

Written by ι Stock Market Media Group Staff — March 3, 2014

Nuvilex (OTCQB: NVLX) investors who have patiently waited for the R&D biotech to reach a point where late-phase clinical trials were a reality, are probably relishing these truly exciting times after a Chicago-based institutional investor committed to fund $27 million dollars toward the company’s clinical trials in advanced inoperable pancreatic cancer.  Leading up to the aforementioned clinical trials, investors can expect to see a list of milestone developments unfold, and for ...

Read More →
0

Drug Makers Could Soon Turn Away From Eli Lilly’s Gemzar and Toward Nuvilex’s Cell Encapsulation

Drug Makers Could Soon Turn Away From Eli Lilly’s Gemzar and Toward Nuvilex’s Cell Encapsulation

Written by ι Stock Market Media Group Staff — August 22, 2013

While Eli Lilly’s (NYSE: LLY) cancer fighting drug Gemzar (gemcitabine) has been on the market since the late 1990s, its success with cancer duly noted, other big pharmaceutical companies are combining their own drugs with  gemcitabine in their own clinical trials in an attempt to improve upon the gemcitabine’s effectiveness when that drug is used alone for the treatment of advanced, inoperable pancreatic cancer, but they’re not finding much success.  ...

Read More →
0

Nuvilex, Inc. Acquisition Could Be Steal of the Century and Worth Billions

Nuvilex, Inc. Acquisition Could Be Steal of the Century and Worth Billions

Written by ι Stock Market Media Group Staff — July 18, 2013

In a recently announced acquisition deal, Nuvilex, Inc. (OTCQB: NVLX), pulled off what can only be described as the steal of the century.  The company was able to secure a deal that allowed it to “cherry-pick” the exact piece of the pie Nuvilex wanted from another company.  And, what was the exact piece of the pie Nuvilex wanted – Bio Blue Bird AG (BBB) and more importantly, its worldwide licenses ...

Read More →
0

Nuvilex, Inc. Phase III Clinical Trials in Strong Hands with Dr. Gerald Crabtree

Nuvilex, Inc. Phase III Clinical Trials in Strong Hands with Dr. Gerald Crabtree

Written by ι Stock Market Media — April 1, 2013

Nuvilex, Inc. (OTCQB: NVLX) CEO, Dr. Robert Ryan knew exactly what he was doing 2 years ago when he announced Dr. Gerald Crabtree would be joining his team as the company’s Chief Operating Officer (COO).  He is the right guy, at the right place, at the right time, and Dr. Ryan is expecting his COO’s extensive expertise to help carry this small biotech across the finish line.

Dr. Gerald Crabtree ...

Read More →
0
ContactUs.com